Acta Group, LLC, The – Trademark Portfolio

Entity Type: 99

Acta Group, LLC, The holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ACTA. The owner is based in Washington, DC, DC.

2200 Pennsylvania Avenue, NW

Suite 100W

Washington, DC, DC 20037

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ACTA
ACTA
Registered 2005

Trademark Classifications

Acta Group, LLC, The's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Acta Group, LLC, The have?

Acta Group, LLC, The has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Acta Group, LLC, The file in?

Acta Group, LLC, The files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 35 covers advertising; business management; business administration; office functions.

What are Acta Group, LLC, The's most well-known trademarks?

Acta Group, LLC, The's registered trademark portfolio includes well-known marks such as ACTA. These are among 1 currently registered trademark in the portfolio.

What is Acta Group, LLC, The's trademark registration success rate?

Acta Group, LLC, The has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.